Kwok C F, Goldstein B J, Muller-Wieland D, Lee T S, Kahn C R, King G L
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215.
J Clin Invest. 1989 Jan;83(1):127-36. doi: 10.1172/JCI113848.
Insulin actions and receptors were studied in capillary endothelial cells cultured from diabetic BB rats and their nondiabetic colony mates. The endothelial cells from diabetic rats of 2 mo duration had persistent biological and biochemical defects in culture. Compared with normal rats, endothelial cells from diabetic rats grew 44% more slowly. Binding studies of insulin and insulin-like growth factor I (IGF-I) showed that cells from diabetic rats had 50% decrease of insulin receptor binding (nondiabetic: 4.6 +/- 0.7; diabetic: 2.6 +/- 0.4% per milligram protein, P less than 0.01), which was caused by a 50% decrease in the number of binding sites per milligram protein, whereas IGF-I binding was not changed. Insulin stimulation of 2-deoxy-glucose uptake and alpha-aminoisobutyric acid uptake were also severely impaired with a 80-90% decrease in maximal stimulation, in parallel with a 62% decrease in insulin-stimulated autophosphorylation (P less than 0.05). 125I-insulin cross-linking revealed an 140-kD alpha subunit of the insulin receptor similar to that in cells from nondiabetic rats, although bands at greater than 200 kD were also detected. The molecular weight of the insulin receptor beta subunit (by SDS-PAGE) was smaller in cells from diabetic than from normal rats (88-90 vs. 95 kD). Neuraminadase treatment of the partially purified insulin receptors decreased the molecular weight of the insulin receptors from nondiabetic rats to a greater degree than its diabetic counterpart. In contrast, Northern blot analysis of insulin receptor mRNAs using human cDNA probes revealed two species of 9.4 and 7.2 kb with no difference in mRNA abundance between cells from diabetic and nondiabetic rats. We conclude that the exposure of capillary endothelial cells to a diabetic milieu in vivo can cause specific and persistent changes in the insulin receptor and insulin action.
对从糖尿病BB大鼠及其非糖尿病同窝大鼠培养的毛细血管内皮细胞中的胰岛素作用和受体进行了研究。病程2个月的糖尿病大鼠的内皮细胞在培养中存在持续的生物学和生化缺陷。与正常大鼠相比,糖尿病大鼠的内皮细胞生长速度慢44%。胰岛素和胰岛素样生长因子I(IGF-I)的结合研究表明,糖尿病大鼠的细胞胰岛素受体结合减少50%(非糖尿病:每毫克蛋白质4.6±0.7;糖尿病:每毫克蛋白质2.6±0.4%,P<0.01),这是由于每毫克蛋白质结合位点数量减少50%所致,而IGF-I结合未改变。胰岛素刺激的2-脱氧葡萄糖摄取和α-氨基异丁酸摄取也严重受损,最大刺激降低80-90%,同时胰岛素刺激的自身磷酸化降低62%(P<0.05)。125I-胰岛素交联显示胰岛素受体的140-kDα亚基与非糖尿病大鼠细胞中的相似,尽管也检测到大于200 kD的条带。糖尿病大鼠细胞中胰岛素受体β亚基的分子量(通过SDS-PAGE)比正常大鼠细胞中的小(88-90 kD对95 kD)。用神经氨酸酶处理部分纯化的胰岛素受体,非糖尿病大鼠胰岛素受体分子量的降低程度大于糖尿病大鼠。相反,用人cDNA探针进行胰岛素受体mRNA的Northern印迹分析显示有9.4和7.2 kb两种类型,糖尿病和非糖尿病大鼠细胞之间的mRNA丰度没有差异。我们得出结论,体内毛细血管内皮细胞暴露于糖尿病环境可导致胰岛素受体和胰岛素作用发生特异性和持续性变化。